Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05882513
What this trial is testing

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

Who this might be right for
NSCLCNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Large-scale testing (Phase 3)Looking for participantsNCT06123754
What this trial is testing

Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer
3D Medicines (Sichuan) Co., Ltd. 390
Large-scale testing (Phase 3)Study completedNCT00136890
What this trial is testing

PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers

Who this might be right for
Non-small-cell Lung Carcinoma
Ontario Clinical Oncology Group (OCOG) 337
Not applicableUnknownNCT06267144
What this trial is testing

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06055465
What this trial is testing

Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Chinese University of Hong Kong 37
Large-scale testing (Phase 3)Looking for participantsNCT05429463
What this trial is testing

Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）

Who this might be right for
Squamous Cell Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 250
Testing effectiveness (Phase 2)Looking for participantsNCT06810609
What this trial is testing

Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

Who this might be right for
Lung Cancer Non-Small Cell Cancer (NSCLC)
University Hospital, Bonn 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT06939127
What this trial is testing

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital 38
Testing effectiveness (Phase 2)Study completedNCT00130780
What this trial is testing

Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Looking for participantsNCT06424899
What this trial is testing

A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Zeng Jian 92
Large-scale testing (Phase 3)Active Not RecruitingNCT03800134
What this trial is testing

Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 825
Testing effectiveness (Phase 2)Looking for participantsNCT06924398
What this trial is testing

Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05319574
What this trial is testing

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT06659042
What this trial is testing

Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
Shanghai Chest Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07323056
What this trial is testing

Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer

Who this might be right for
EGFR-mutant Non-small Cell Lung CancerPotentially Resectable
Shanghai Pulmonary Hospital, Shanghai, China 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465329
What this trial is testing

Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT07274761
What this trial is testing

Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.

Who this might be right for
Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung CancerNon Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 24
Testing effectiveness (Phase 2)Looking for participantsNCT06532591
What this trial is testing

Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC

Who this might be right for
NSCLC
Sichuan Cancer Hospital and Research Institute 20
Not applicableStudy completedNCT04808050
What this trial is testing

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 748
Next Page